相关实验视频

Updated: May 21, 2025

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

3.9K

用ECMO和奥西默蒂尼布治疗的EGFR 19外因子缺陷双边扩散LUAD与ARDS中的血小板减少:一个病例报告

Donghai Liang1, Fei Zhou1, Chen Xu2

  • 1Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China.

Case reports in oncology
|March 21, 2025
PubMed
概括

本案例研究探讨使用ECMO,抗感染药物和EGFR-TKI疗法用ARDS治疗EGFR突变肺腺癌. 虽然有效,但不可逆转的血小板缺血是已知的不良事件.

关键词:
急性呼吸困扰综合征是什么双边扩散的肺腺癌.身体外膜氧化器的氧化奥西默蒂尼布 (Osimertinib) 是一种药物.血小板减少症 (Thrombocytopenia) 是一个严重的疾病.

更多相关视频

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.7K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

7.9K

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
119